Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma

Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K. Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A. Gertz, Wilson I. Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma M. Warsame, Robert A. Kyle, S. Vincent RajkumarShaji K. Kumar

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number11
JournalBlood cancer journal
Issue number1
StatePublished - Dec 2023

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this